Glycate is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by Intra-sana Laboratories. The primary component is Glycopyrrolate.
| Product ID | 80056-160_0b245593-da99-460d-b587-aacc099fa055 |
| NDC | 80056-160 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Glycate |
| Generic Name | Glycopyrrolate |
| Dosage Form | Tablet |
| Route of Administration | ORAL |
| Marketing Start Date | 2022-04-01 |
| Marketing Category | ANDA / |
| Application Number | ANDA091522 |
| Labeler Name | Intra-Sana Laboratories |
| Substance Name | GLYCOPYRROLATE |
| Active Ingredient Strength | 2 mg/1 |
| Pharm Classes | Anticholinergic [EPC], Cholinergic Antagonists [MoA] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2023-12-31 |
| Marketing Start Date | 2022-04-01 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 15370-160 | GLYCATE | GLYCATE |
| 59547-210 | Glycate | Glycate |
| 0259-0501 | Cuvposa | glycopyrrolate |
| 0143-1250 | Glycopyrrolate | Glycopyrrolate |
| 0143-1251 | Glycopyrrolate | Glycopyrrolate |
| 0143-9584 | Glycopyrrolate | Glycopyrrolate |
| 0143-9585 | Glycopyrrolate | Glycopyrrolate |
| 0143-9586 | Glycopyrrolate | Glycopyrrolate |
| 0143-9587 | Glycopyrrolate | Glycopyrrolate |
| 0143-9679 | Glycopyrrolate | Glycopyrrolate |
| 0143-9680 | Glycopyrrolate | Glycopyrrolate |
| 0143-9681 | Glycopyrrolate | Glycopyrrolate |
| 0143-9682 | Glycopyrrolate | Glycopyrrolate |
| 0259-0502 | Glycopyrrolate | Glycopyrrolate |
| 0404-9867 | GLYCOPYRROLATE | GLYCOPYRROLATE |
| 0404-9868 | GLYCOPYRROLATE | GLYCOPYRROLATE |
| 0404-9869 | GLYCOPYRROLATE | GLYCOPYRROLATE |
| 0404-9870 | GLYCOPYRROLATE | glycopyrrolate |
| 0517-4601 | Glycopyrrolate | Glycopyrrolate |
| 0078-0662 | SEEBRI NEOHALER | glycopyrrolate |
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
![]() GLYCATE 85773181 4506691 Live/Registered |
Argent Development Group, LLC 2012-11-06 |